Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03130790
Recruitment Status : Active, not recruiting
First Posted : April 26, 2017
Last Update Posted : November 19, 2020
Sponsor:
Information provided by (Responsible Party):
Aslan Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : December 20, 2018
Estimated Study Completion Date : September 2022